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Abstract In this study, we investigate the potentiating effect
of PACAP27 on cholinergic neuromuscular transmission in
the recently discovered flexor muscles of the land snail, Helix
pomatia. Using immunohistochemistry, we show that PACAP
and PAC1 receptors are present in nerve fibers innervating the
flexor muscles but not in the muscle itself. We also observed
that PACAP27 exerts both pre- and postsynaptic effects on the
cholinergic synapse and performed tests using a broad spec-
trum of chemicals in order to explore the possible intracellular
pathways through which PACAP mediates its stimulatory ef-
fect. Our pharmacological data demonstrate that PACAP27
presynaptically enhances the release of acetylcholine by acti-
vating the adenylate cyclase-cAMP-PKA pathway. Postsyn-
aptically, PACAP27 was found to enhance muscle contractil-
ity by PKC-mediated signaling pathway resulting in an in-
creased Ca2+ release from intracellular stores. These findings
suggest that regulation of Ca2+ release may contribute to the
stimulatory effect of PACAP. Our data are the first
demonstration of the potentiating effect of PACAP27 at the
molluscan excitatory neuromuscular contact.
Keywords Snail . Muscle contraction . Neuromuscular
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Introduction
Pituitary adenylate cyclase-activating polypeptide (PACAP)
belongs to the vasoactive intestinal peptide (VIP)-secretin-
growth hormone superfamily of regulatory peptides (Arimura
1992). PACAP shows a remarkable amino acid sequence sim-
ilarity at the N-terminal domain across higher and lower ver-
tebrate species, and even invertebrate species such as worms,
insects, and molluscs (Kiss and Pirger 2013). Such a high
degree of sequence homology represents conservation during
evolution and indicates that PACAP and its receptor mole-
cules could be involved in the modulation of several basic
physiological functions (Cardoso et al. 2007; Sherwood
et al. 2000).
PACAP and its receptors are widely distributed in the cen-
tral nervous system (CNS) and in the periphery of vertebrates
and invertebrates. In vertebrates, two types of receptors have
been characterized according to their relative affinities for PA-
CAP and VIP: PAC1R and VPAC1/VPAC2 (Cardoso et al.
2007; Vaudry et al. 2009). The presence of both types of
receptors is demonstrated in the snail CNS, making molluscs
suitable models for studying the cellular mechanisms of PA-
CAP (Hernádi et al. 2008; Kaufmann et al. 1995; Pirger et al.
2010).
The wide distribution of PACAP and its receptors implies
that the peptide exerts pleiotropic physiological role to mod-
ulate ion-channels and synaptic function, by binding to spe-
cific cell-surface receptors and triggering an array of
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intracellular signaling pathways (Vaudry et al. 2009). Co-
existence and/or co-release of PACAP and classical transmit-
ters have already been demonstrated in different parts of the
vertebrate CNS and also at the periphery (Fahrenkrug and
Hannibal 2004). For example, it has been established that
PACAP increases presynaptic acetylcholine (ACh) release at
neuronal nicotinic synapses in cultured ciliary ganglion neu-
rons by activation of PACAP/PAC1R via adenylate-cyclase
(AC)-dependent signaling that leads to the stimulation of
NO production (Pugh et al. 2010). PACAP also modulates
synaptic activity in several neuronal regions by increasing
release of ACh from septal cholinergic fibers or in the CA1
region (Masuo et al. 1993; Roberto and Brunelli 2000). In the
guinea pig mesenteric ganglion, PACAP enhances the level of
nicotinic cholinergic transmission presynaptically and acts di-
rectly on postsynaptic neurons to increase membrane excit-
ability (Ermilov et al. 2004). The excitatory action of PACA
P has also been observed in the internal anal sphincter smooth
muscle of the opossum, where it is thought to activate PACAP
receptors of postganglionic nerve terminals making neuro-
muscular contacts (Rattan and Chakder 1997). In Drosophila,
PACAP generates two temporally distinct responses on larval
body wall musculature. First, the peptide generates an early
inward current, thus depolarizes the membrane and the late
response is an enhancement of voltage-dependent K+ current
(Zhong and Pena 1995).
PACAP also modulates the effects of transmitters at
inhibitory smooth muscle neuromuscular junctions, where
it elicits relaxation by increasing AC activity or by con-
trolling smooth muscle mechanical activity. It acts directly
on muscle cells via PACAP preferring receptors or indi-
rectly by stimulating NO synthesis (Imoto et al. 1998;
Lecci et al. 2002; Takeuchi et al. 2004; Zizzo et al.
2004). An inhibitory action of PACAP has been observed
in the gastrointestinal tract of different vertebrates and has
been attributed to the activation of apamine sensitive,
Ca2+-dependent K+-channels (Kishi et al. 1996; Schworer
et al. 1992). PACAP induces concentration-dependent and
substantial relaxations of carotid arteries of young rats
(Vamos et al. 2014). Furthermore, the peptide evokes cer-
ebellar artery dilation by activation of ATP-sensitive and
large-conductance Ca2+-activated K+ channels (Koide
et al. 2014). In all cases, mentioned above the channel
stimulation was likely due to the activation of adenylyl
cyclase and an increase of cAMP. Preliminary experi-
ments have demonstrated that PACAP markedly potenti-
ates contractions of the recently described flexor muscles
(FM) of the upper tentacles of the land snail evoked by
synaptically released or by exogenously applied ACh
(Hernádi and Teyke 2012; Kiss et al. 2013; Krajcs et al.
2012). Therefore, the main objective of the present study
was to explore the mechanism underlying the potentiation
of muscle contraction by PACAP.
Materials and Methods
Preparation and Contraction Measurement
Adult specimens of the pulmonate snail, Helix pomatia, were
collected in the surrounding area. FMs of the posterior tenta-
cles were isolated, and their isotonic contraction was recorded
as described previously (Krajcs et al. 2012). Briefly, one end
of a single muscle was fixed into a slot cut out of Plexiglass,
and the other end was free. Changes in muscle length were
measured in control and test solutions using the ocular mi-
crometer of a stereomicroscope. Contractions were expressed
as a percentage shortening of the muscle compared to its rest-
ing length. Chemicals were dissolved in snail physiological
solution containing (in mM): 80 NaCl, 4 KCl, 10 CaCl2, 5
MgCl2, and 10 Tris–HCl (pH = 7.4), and were applied onto
the muscle via a rapid gravity perfusion system. The geometry
of the perfusion chamber enabled a fast exchange of solutions
(2–3 s). All experiments used preparations containing the ol-
factory nerve connecting the cerebral ganglion (CG) with the
FM. The CG and part of the olfactory nerve were placed in a
pit of the recording chamber separated from the muscle by a
Vaseline gap. For the electrical stimulation of innervated mus-
cles, a pair of silver-hooked electrodes was placed under the
nerve. Electrical pulses of 10 ms and 5–10 V, 1–1.5 Hz were
applied to the olfactory nerve, and contractions of the M3 FM
were recorded (Hernádi and Teyke 2013).
Immunohistochemistry
The posterior tentacles with the three recently described ten-
tacle FMs (Hernádi and Teyke 2012) were dissected and fixed
in 4 % paraformaldehyde (buffered with 0.1 M phosphate
buffer, pH 7.4) for 6 h at 4 °C. The FMs were separated from
the tentacles and used for immunohistochemistry (IHC) as
whole mount preparations. The preparations were incubated
for 24 h at room temperature with either the anti-PAC1R an-
tibody, or the anti-PACAP antibody. Anti-PAC1R antibodies
purchased from two different producers were tested. The epi-
topes of the two PACAP receptor antibodies were different.
Anti-PACAP and anti-PAC1R from Sigma were diluted to
1:500 in PBS-TX-BSA. After a short wash in PBS-TX, the
immunoreaction was visualized using the One-Step Polymer-
HRP IHC Detection System (anti rabbit diluted 1:4 in PBS-
TX-BSA, BioGenex, USA). Anti-PAC1R antibody from
Abcam was diluted to 1:100 in PBS-TX-BSA. The immuno-
reaction was visualized using NL-493 conjugated anti-rabbit
IgG, diluted to 1:200 (R&D Systems, Biomedica Kft, Buda-
pest, Hungary). No immunoreactivity was observed using
preabsorption and method controls. The specificity of anti-
PAC1R antibody (Sigma) had already been described
(Hernádi et al. 2008).
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Following a short wash in PBS-TX, the samples were
mounted in PBS-glycerol (2:1) and viewed under a light mi-
croscope or a fluorescence microscope equipped with the ap-
propriate filters.
Chemicals
Acetylcholine chloride (ACh), forskolin, N6,2 ′-O-
dibutyryladenosine 3′,5′-cyclic monophosphate sodium salt
(DB-cAMP), chelerythrine chloride (ChelCl), ruthenium red
(RR), cadmium chloride (CdCl2), potassium chloride (KCl),
and anti-pituitary adenylate cyclase-activating polypeptide
type 1 receptor (PAC1R) antibody (rabbit polyclonal,
P8872) were purchased from Sigma (Budapest, Hungary).
Another anti-PAC1R antibody was purchased from Abcam
(rabbit polyclonal, ab95278, Cambridge, UK). Anti-PACAP
antibody (rabbit polyclonal) was purchased from Abcam
(ab174982). H-7 dihydrochloride (H-7) was purchased from
Biomedica (Budapest, Hungary). Decamethylene-bis-
dimethylammonium bromide (DMDA), a nicotinic AChR an-
tagonist, was purchased from Fluka AG (Buchs, Switzerland).
M65 was purchased from Bachem (Bubendorf, Switzerland).
PACAP38, PACAP27, and PACAP6-27 were synthetized at
the Department of Medical Chemistry, University of Szeged
(Szeged, Hungary).
Statistical Analysis
Data are presented as mean ± S.E.M. Statistical significance
was assessed in all experiments using a paired sample t test.
Statistical significance was accepted when p < 0.05 or
p < 0.01.
Results
Effect of PACAP on Nerve-Evoked Contractions
(Presynaptic Mechanism)
FM contractions evoked by stimulating the olfactory nerve
were mimicked by external ACh application. In the presence
of nicotinic acetylcholine receptor antagonists, contractions
were powerfully attenuated, suggesting that ACh was released
from nerve endings (Kiss et al. 2014). Direct application of
PACAP38 or PACAP27 at 10−7–10−4 M did not cause a
change in the resting tone, or in the phasic contraction of the
muscle (data are not shown). However, when muscles were
pretreated for 15 min with 10−7 M PACAP27, nerve evoked
contractions were significantly potentiated (Fig. 1a). No such
effect was observed when muscles were pretreated with PA-
CAP38. The potentiating effect of PACAP27 was statistically
significant when it was added to the muscle compartment of
the organ chamber (67 % potentiation on average), and also
observed when added to the ganglionic compartment (27 %,
although not significant). This observation underpins the hy-
pothesis that PACAP27 exerts potentiating effect both pre-
and postsynaptically. The potentiation was long-lasting, and
full recovery was obtained washing with control physiological
solution for 15–20 min. The potentiating effect of PACAP27
on nerve evoked contractions was effectively antagonized by
truncated peptide PACAP6-27 (an antagonist of PACAP re-
ceptor), suggesting that PACAP was released upon nerve
stimulation and that a specific PACAP-sensitive receptor
was involved (Fig. 1b). These observations imply that there
is a presynaptic interaction between the neuropeptide and neu-
rotransmitter, suggesting that PACAP27 is released simulta-
neously with ACh when the olfactory nerve is stimulated.
Fig. 1 PACAP27 but not PACAP38 enhances muscle contractions. a
Pretreatment with 10−7 M PACAP27, applied to the muscle
compartment, increased by 67 % the amplitude of muscle contractions
evoked by electrical stimulation (stim) of the olfactory nerve. When
PACAP27 was applied to the ganglionic compartment (ggl)
contractions increased by 24 %. Application of PACAP38 over the
muscle had no effect, while application to the ggl augmented the
contractions by 27 %. b The PACAP receptor antagonist PACAP6-27
(10−6 M) effectively antagonized the stimulatory effect of 10−7 M
PACAP. Asterisks indicate a significant difference from the control
value at *p < 0.05, n = number of muscles. All pretreatments lasted for
15 min
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To examine the potential modulatory role of PACAP for
nicotinic neuromuscular transmission, its localization in the
olfactory nerve, which innervates all FMs, was next
established using PACAP and PAC1R antibody (Ab) labeling.
Consistent with a modulatory role, PACAP27 Ab
immunolabeled fibers were observed in the olfactory nerve
(Fig. 2). Intense PACAP-LI was present in axon bundles run-
ning along the longitudinal axes of each of the FMs (Fig. 2a);
the labeled axons also projected thin perpendicular side
branches onto the muscle fibers (Fig. 2b, c).
App l y i n g PAC1R Ab r ev e a l e d PAC1R - l i k e
immunoresponse in axons within thick fiber trunks running
longitudinally in the muscles (Fig. 3a). Fine varicose side
branches of PAC1R-LI containing axons, running both longi-
tudinally and transversally, were seen both on the surface and
deep within the muscles (Fig. 3b). The labeled axons densely
innervated FMs and terminated on muscle fibers, displaying
an endplate like appearance (Fig. 3c). Similar appearance of
PAC1R-labeled axons could be observed in cross-section of
the muscle using another PACAP receptor antibody (Fig. 3d).
The anti-PAC1R antibodies revealed that these receptors were
confined exclusively to nerves innervating the FM but mus-
cles supporting presynaptic action of PACAP27. Further evi-
dence for presynaptic modulation by PACAP was obtained
applying AChR blocker DMDA.
DMDAwas found to reduce nerve-elicited contractions by
40–50 % both in control- and PACAP27-pretreated muscles
(Fig. 4a). These data provide supporting evidence first that
ACh was released from nerve terminals during stimulation
and second that the stimulating effect of PACAP27 was due
to the increased transmitter release. The blocking effect in
both cases was statistically significant.
Since PACAP27 acts via PAC1R, a selective high-affinity
G-protein coupled receptor, the role of the intracellular signal-
ing cascade was investigated. Specific activators and inhibi-
tors of AC were applied during olfactory nerve-evoked FM
contractions and compared with those obtained in muscles
pretreated with 10−7 M PACAP27. Forskolin, an activator of
AC, and DB-cAMP, a permeable analog of cAMP, both en-
hanced muscle contractions (Fig. 4b). These data suggest that
PACAP27 enhances ACh release via presynaptic activation of
cholinergic nerve terminals in the FM. Next, the possible in-
volvement of protein kinases was evaluated using ChelCl and
H-7. ChelCl, a specific PKC inhibitor, did not change the
PACAP27 induced potentiation of the nerve evoked contrac-
tions (Fig. 4b). In contrast, H-7, a PKA, PKC, PKG, and
myosin light-chain kinase inhibitor significantly attenuated
these contractions (Fig. 4b).
Effect of PACAP on ACh-Elicited Contraction
(Postsynaptic Mechanism)
To assess whether postsynaptic mechanisms were also in-
volved in the contraction-enhancing effect of PACAP27,
ACh (10−5 M) was next directly applied to the denervated
muscle. The relatively high concentration of ACh
(EC50 = 6 × 10
−6 M) assured the prevalence of a postsynaptic
site of action (Krajcs et al. 2014). Pretreating the muscle with
10−7 M PACAP27 for 15 min induced a significant enhance-
ment of the ACh evoked contraction (Fig. 5). This enhance-
ment was successfully attenuated in the presence of 10−6 M
PACAP6-27 or M65, suggesting that specific PACAP recep-
tors were involved. However, PAC1R receptors could not be
identified in the muscles using immunohistochemistry (see
Fig. 2 PACAP27
immunolabeled elements in the
flexor muscles. a In the M1 flexor
muscle PACAP27-LI axons are
shown in nerve trunks (large
arrows) running longitudinally in
the muscle. b In the nerve fiber
trunks, numerous labeled axons
can be observed (thin black
arrows). The axons may send off
transversally running varicose
axonal side branches (arrow
heads). c Fine varicose axon
branches running longitudinally
on the surface of the muscle can
also be seen (arrow heads). Bars
represent 50 μm
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Fig. 3). The potentiating effect of PACAP27 on ACh-evoked
contractions was blocked in the presence of a PKC and PKA
inhibitor, indicating that the potentiating effect of PACAP27 is
mediated by a cAMP/PKA- and PKC-dependent mechanism
(Fig. 5). Forskolin did not have statistically significant effect
on the ACh-elicited contraction suggesting that PACAP post-
synaptically used different intracellular pathway from that ob-
served presynaptically. PACAP27 therefore appears to exert
its potentiating effect on the FM contraction by acting on
different receptors or directly on the muscle, either by increas-
ing the extracellular Ca2+-influx through voltage-dependent
Ca2+ channels (VDCC) or by increasing Ca2+ release from
intracellular stores.
To test the power of PACAP to induce a rise in cytosolic
Ca2+ concentration, high K+-evoked contractions were com-
pared in control and in PACAP27-pretreated muscles
(Fig. 6a). In PACAP27-pretreated muscles, KCl-evoked
contractions were not potentiated; in fact, they decreased on
average by ∼32.4 %. In the presence of 100 μMCd2+, ∼69 %
of KCl-evoked contractions were decreased, suggesting the
involvement of Ca2+ influx via VDCCs in the KCl-induced
contraction (Fig. 6a). Next, the effect of PACAP27 on ACh-
evoked contractions in Ca2+-free solution was assessed. The
mean amplitude of the ACh-evoked contractions of muscles
placed in Ca2+-free extracellular solution decreased by ∼60 %
compared to the control contractions, supporting the view that
an inward Ca2+ movement from the extracellular space was
involved (Fig. 6b).When FM placed in Ca2+-free solution was
challenged with PACAP27 for 15 min, the ACh-evoked
Fig. 3 PAC1-R immunolabeled elements in the flexor muscles. a
PAC1R-LI fiber trunks (thick arrows) run longitudinally in the muscle.
Labeled axons in the trunks give off varicose side branches (arrow heads)
which densely innervate the muscles. b Varicose side branches (arrow
heads) run both longitudinally and transversally on the surface of the
muscle. c In the deeper layer of the muscle, the labeled axons (thin
arrow) give off transversal varicose side branches (arrow heads) which
terminate on muscle fibers and display an endplate-like appearance. d
Cross-section of the muscle showing longitudinally (thick arrows) and
transversally (arrow heads) running, PAC1R-containing axons. Bars
represent 50 μm (a–c) or 25 μm (d)
Fig. 4 a Pretreating the muscle with 10−5 M DMDA significantly
reduced the muscle contractions evoked by electrical nerve stimulation.
10−5 M DMDA completely blocked the potentiating effect of 10−7 M
PACAP27. b PACAP27 acts via second messenger signaling pathway.
Similarly to PACAP27, pretreatment of the muscle with forskolin
(10−5 M) and DB-cAMP (10−6 M) for 15 min increased the nerve
stimulation-evoked muscle contractions by 63 and 34 %, respectively.
Joint application of PACAP27 (10−7 M) and H-7 (10−5 M) decreased
the contractions by 30 %, while pretreatment of PACAP27 (10−7 M)
and chelerythrine chloride (ChelCl, 10−6 M) at the same time
augmented the contractions by 77 %. Asterisks indicate a significant
difference from the control value at *p < 0.05, **p < 0.01, n = number
of muscles. All pretreatments lasted for 15 min
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contraction increased by ∼70 %. The ratio of the contraction
recorded in PACAP-treated and non-treated muscle in control
and Ca-free solution was nearly equal, 2 and 1.7, respectively.
The ACh-evoked contraction recorded in Ca2+-free solution
was further decreased in the presence of RR, which is a
blocker of Ca2+-release from mitochondria and ryanodine/
caffeine-sensitive intracellular stores (Fig. 6b). Collectively,
these data revealed that the underlying mechanism of
PACAP27-induced potentiation of ACh-evoked contractions
involved the increase of cytosolic free Ca2+ from intracellular
stores.
Discussion
In this study, the effect of PACAP on the contractions evoked
by stimulation of the olfactory nerve or by exogenous ACh
application was studied in the FM of the upper tentacle of the
snail. PACAP27 caused an increase in the amplitude of mus-
cle contractions in both cases. The goal of this study was to
investigate the signaling pathway that couples PACAP to a
potentiation of both synaptically and exogenously applied
ACh-elicited muscle contraction, and to unravel the site of
PACAP action.
The data shown here provide pharmacological, physiolog-
ical, and immunohistochemical evidence in support of the
hypothesis that PACAP27, but not PACAP38, increases nerve
evoked contractions by pre- and postsynaptic mechanisms
working together at the gastropod neuromuscular junction.
In order to determine whether the effect of PACAP was elic-
ited through pre- and/or postsynaptic mechanisms, the locali-
zation of PACAP and its receptors was assessed by IHC. It
was observed that PACAP27-LI and PAC1R-LI immunoreac-
tive nerve fibers were present throughout the muscles. Based
on distribution pattern of labelled elements, we suggested that
Fig. 5 Effect of PACAP27 on the externally applied ACh-evokedmuscle
contractions. Forskolin (10−5M) pretreatment did not increase the 10−5M
ACh-evoked contractions. 10−7 M PACAP27 pretreatment augmented
ACh-elicited contractions by 104 %. However, when PACAP27 was
applied together with10−6 M PACAP6-27, the increasing effect of
PACAP was completely blocked. Applying M65 (10−6 M) together
with PACAP27, the effect of PACAP was almost completely blocked.
Similarly, chelerythrine chloride (ChelCl, 10−6 M) and H-7 (10−5 M)
inhibited the increasing effect of PACAP by ∼67 and 63 %,
respectively. Dashed line shows ACh contractions marked as 100 %.
Asterisks indicate a significant difference from the control value at
*p < 0.05. # indicates significant difference from the PACAP-
augmented contractions at p < 0.05, ## indicates significant difference
from the PACAP-augmented contractions at p < 0.01, n = number of
muscles. All pretreatments lasted for 15 min
Fig. 6 Effect of PACAP27 on cytosolic Ca2+ level. a 40mMKCl evoked
muscle contractions by 35 %. After pretreating the muscle with 100 μM
CdCl2, the KCl-evoked contractions were decreased by 64 %. Applying
10−7 M PACAP27 reduced the KCl-elicited contractions by 32 %. The
recovery was complete washing the preparations with physiological
saline. b Effect of PACAP27 on ACh-evoked contractions in Ca2+-free
ringer solution. 10−5 M ACh evoked muscle contractions increased by
∼70 % following 10−7 M PACAP27 pretreatment. The potentiating effect
of PACAP was decreased by 60 % pretreating the muscle with 40 μM
ruthenium red (RR) compared to the PACAP27+ACh-elicited
contractions. Asterisks indicate a significant difference from the control
value at *p < 0.05, **p < 0.01, n = number of muscles. All pretreatments
lasted for 15 min
J Mol Neurosci (2015) 57:492–500 497
at least part of PACAP-containing fibers were localized pre-
synaptically to the ACh-containing nerve endings. The pres-
ence of PACAP-LI and PAC1R immunoreactive nerve fibers
in the FM, verified here, confirms therefore that the peptide
acted presynaptically to enhance nerve evoked contractions
and that the effect of PACAP27 is mediated by specific
PAC1Rs. However, the ability of PACAP27 to enhance
nerve-evoked contractions may be explained by different
mechanisms, namely, (a) by presynaptic mechanisms when
PACAP27 binds to specific, presynaptically localized
PAC1Rs leading to the increased release of neurotransmitter,
(b) by postsynaptic mechanisms, whereby PACAP27 in-
creases the contractility or facilitates excitation-contraction
coupling of the muscle in response, or (c) both, when presyn-
aptic and postsynaptic mechanisms work together.
Previously, it has been described that contractions of the
FM evoked by stimulation of the olfactory nerve are mim-
icked by external ACh, suggesting that ACh is an excitatory
transmitter at the neuromuscular contacts. On binding to the
postsynaptic, slowly desensitizing αBgTx-sensitive α7-like
AChRs, ACh evokes a concentration-dependent contraction
of the FM with EC50 = 6 × 10
−6 M (Kiss et al. 2014; Krajcs
et al. 2014).
PACAP27 had no significant effect on the resting tone of
the FM. The data presented here suggest, however, that PACA
P27 is potentially able to increase synaptically elicited
contraction presumably by increasing the amount of ACh re-
leased at the neuromuscular contact.
The ability of PACAP to modulate ACh-containing nerve
terminals throughout the nervous system of vertebrates is well
known (Liu et al. 2000; Margiotta and Pardi 1995; Pugh et al.
2010). Evidence indicates that PACAP stimulates ACh release
from presynaptic cholinergic terminals in rat hippocampus
and that this action is highly Ca2+-dependent (Masuo et al.
1993). Less is known about the effect of PACAP at the excit-
atory neuromuscular junction in either vertebrates or inverte-
brates (Parkman et al. 1997; Yoshitomi et al. 2002). PACAP
has been shown to be distributed in the myenteric neurons
throughout the gastro-intestinal tract, where it exerts both in-
hibitory and excitatory effects depending on the sites and
mechanisms of action (Rattan and Chakder 1997). The inhib-
itory effects may be direct while the excitatory may be indi-
rect, and appear to be mediated via the activation of specific
PAC1Rs (Katsoulis et al. 1993).
Here, investigation into the intracellular mechanisms of the
presynaptic PACAP27 effect revealed that the increase in FM
contraction elicited by nerve stimulation was attenuated by the
protein kinase A inhibitor H-7. In contrast, ChelCl (PKC in-
hibitor) had no effect. PACAP also increased cAMP accumu-
lation by stimulating adenylate cyclase (AC) activity, because
both forskolin and a membrane permeable cAMP analog in-
creased synaptically evoked contractions. These observations
Fig. 7 Schematic drawing illustrates the possible pathways, via which
PACAP develops its enhancing effect on contraction. Acting
presynaptically, PACAP27 binds to PAC1Rs of the nerve endings and
through the AC-cAMP-PKA pathway stimulates the ACh release. ACh
activates the non-selective cation channels (NSCCs), and it results in an
elevated Na+ influx, which causes membrane depolarization, leading to
the opening of voltage-dependent calcium channels (VDCCs). Elevation
of [Na+]i inhibits the Na
+/Ca2+ exchanger and the less efflux of Ca2+
contributes to the rise of [Ca2+]i. Postsynaptically, PACAP may have a
direct positive effect on the intracellular Ca2+ stores through PKC-
mediated pathway. The final effect is the elevation of the intracellular
Ca2+ level and therefore the increase of muscle contraction
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indicate that the effect of PACAP on muscle contraction rep-
resents signaling mechanisms that involve the activation of
PKA presynaptically. Only PAC1Rs, which couples via AC/
PKA-mediated signal transduction, were required to enhance
neuromuscular transmission. Taken together, these results in-
dicate that cyclic nucleotides and cyclic-nucleotide-dependent
protein kinases are necessary components of the pathway that
underlies presynaptic modulation by this peptide. The data
presented here are the first to demonstrate the potentiating
effect of PACAP at the neuromuscular contact in molluscs.
Pharmacological experiments suggested, however, that
both a postsynaptic and presynaptic action of PACAP27 were
present, because exogenously applied ACh-evoked contrac-
tions were also potentiated. Interestingly, these contractions
were not affected by forskolin suggesting a different intracel-
lular signaling pathway; however, contractions were signifi-
cantly attenuated in the presence of PACAP6-27 and M65
although IHC failed to localize PAC1Rs on the muscle using
the same antibodies as for nerves innervating the muscle. To
explain the positive immunoresponse, we have different pos-
sibilities: (1) Eight isoforms of PAC1Rs, resulting from alter-
native splicing, have been characterized so far (Payet et al.
2003); therefore, we cannot exclude that the PAC1R Ab used
in these experiments was unable to recognize the PACAP
receptor variant localized on the muscle cells. (2) It is also
possible that VPACR1 or VPACR2 is present on the FM, as
it has been demonstrated in smooth muscle cells of mamma-
lian stomach (Vaudry et al. 2009). However, this possibility
was not examined by immunohistochemistry. Bearing in mind
that PACAP could facilitate contractions of the FM via a num-
ber of mechanisms, an alternative explanation would be a
direct effect on the muscle not requiring specific receptors. It
has been shown previously that caffeine is able to elicit con-
traction even in Ca2+-free solution, involving an activation of
caffeine sensitive Ca2+ stores that can be blocked by RR
(Krajcs et al. 2012). In this study, the enhancement of the
ACh-evoked contraction by PACAP was observed both in
normal and Ca2+-free solution, clearly showing that voltage-
dependent Ca2+ channels were not involved in PACAP-
induced Ca2+ release. The ratio of PACAP27-induced poten-
tiation in Ca2+-free solution was almost the same as in a solu-
tion of normal ion-content, supporting the conclusion above.
Moreover, the potentiating effect of PACAP on ACh-evoked
contraction was still observed even when VGCCs were
blocked by cadmium. When ryanodine/caffeine sensitive
Ca2+-release was inhibited by RR, the potentiating effect of
PACAP27 was significantly blocked, confirming our conclu-
sion that PACAP stimulated Ca2+-release from intracellular
stores through a PKC dependent pathway. Thus the possibility
exists that PACAP may enhance muscle contraction not only
by increased cAMP production, but also by mobilizing cyto-
solic Ca2+ concentrations. Direct measurement of the cytosol-
ic Ca2+ level was not performed, however, it is known that
PACAP is able to increase cytosolic Ca2+ concentration in a
number of cell types including nerve, adrenal medulla chro-
maffin and pancreatic β-cells (Masuo et al. 1993; Payet et al.
2003).
The mechanisms of PACAP-induced potentiation of ACh-
elicited contraction are summarized in Fig. 7. Thus, it appears
that PACAP is able to utilize a variety of mechanisms by
which it can regulate the excitability of contractions of the
FM, including presynaptic regulation of ACh release, as well
as the post-synaptic regulation of contractility by increasing
the release of Ca2+ from intracellular stores.
Acknowledgments We thank Zsanett Szarka for technical help. The
work was supported by TÁMOP-4.2.2.A-/11/1 KONV-2012-0024 grant
to T.K, as well as PD109099 and KTIA-NAP-13-2-2014-0006 (National
Brain Research Program) grants to Z. P.
References
Arimura A (1992) Pituitary adenylate-cyclase activating polypeptide
(PACAP) - discovery and current status of research. Regul Pept
37:287–303
Cardoso JC, Vieira FA, Gomes AS, Power DM (2007) PACAP, VIP and
their receptors in the metazoa: insights about the origin and evolu-
tion of the ligand-receptor pair. Peptides 28:1902–1919
Ermilov LG, Schmalz PF, Miller SM, Szurszewski JH (2004) PACAP
modulation of the colon-inferior mesentric ganglion reflex in the
guinea pig. J Physiol 560:231–247
Fahrenkrug J, Hannibal J (2004) Neurotransmitters co-existing with VIP
or PACAP. Peptides 25:393–401
Hernádi L, Teyke T (2012) Novel triplet of flexor muscles in the posterior
tentacles of the snail, Helix pomatia. Acta Biol Hung 63:123–128
Hernádi L, Teyke T (2013) Neuronal background of positioning of the
posterior tentacles in the snail Helix pomatia. Cell Tissue Res 352:
217–225
Hernádi L, Pirger Z, Kiss T, Németh J, Mark L, Kiss P, Tamas A, Lubics
A, Toth G, Shioda S, et al. (2008) The presence and distribution of
pituitary adenylate cyclase activating polypeptide and its receptor in
the snail Helix pomatia. Neuroscience 155:387–402
Imoto A, Inoue R, Tanaka M, Ito Y (1998) Inhibitory NANC neurotrans-
mission in choledocho-duodenal junction of rabbits-a possible role
of PACAP. J Auton Nerv Syst 70:189–199
Katsoulis S, Clemens A, Schwörer H, CreutzfeldtW, SchmidtWE (1993)
Pituitary adenylate cyclase activating polypeptide (PACAP) is a po-
tent relaxant of the rat ileum. Peptides 14:587–592
Kaufmann W, Kerschbaum HH, Hauser-Kronberger C, Hacker GW,
Hermann A (1995) Distribution and seasonal variation of vasoactive
intestinal (VIP)-like peptides in the nervous system of Helix
pomatia. Brain Res 695:125–136
Kishi M, Takeuchi T, Suthamnatpong N, Ishii T, Nishio T, Hata F,
Takewaki T (1996) VIP and PACAP mediate nonadrenergic,
noncholinergic inhibition in longitudinal muscle of rat distal colon:
involvement of activation of charybdotoxin- and apamin-sensitive
K+ channels. Br J Pharmacol 119:623–630
Kiss T, Pirger Z (2013) Multifunctional role of PACAP-like peptides in
molluscs. Protein Pept Lett 20:628–635
Kiss T, Pirger Z, Reglodi D, Tóth G, Krajcs N (2013) PACAP signaling
modulates acetylcholine release at the neuromuscular nicotinic con-
tacts of the land snail. J Mol Neurosci 51:S221–S222
J Mol Neurosci (2015) 57:492–500 499
Kiss T, Krajcs N, Pirger Z, Hernádi L (2014) Nicotinic acetylcholine
receptors containing the α7-like subunit mediate contractions of
muscles responsible for space positioning of the snail,Helix pomatia
L. tentacle. PLoS ONE 9:e109538
Koide M, Syed AU, Braas KM, May V, Wellman GC (2014) Pituitary
adenylate cyclase activating polypeptide (PACAP) dilates cerebellar
arteries through activation of large-conductance Ca2+-activated
(BK) and ATP-sensitive (KATP) K
+ channels. J Mol Neurosci 54:
443–450
Krajcs N, Márk L, Elekes K, Kiss T (2012) Morphology, ultratsructure
and contractile properties of muscles responsible for superior tenta-
cle movements of the snail. Acta Biol Hung 63:129–140
Krajcs N, Hernádi L, Elekes K, Kimura S, Kiss T (2014) Excitatory
neurotransmitters in the tentacle flexor muscles responsible for
space positioning of the snail olfactory organ. Invertebr Neurosci
14:59–69
Lecci A, Santicioli P, Maggi CA (2002) Pharmacology of transmission to
gastrointestinal muscle. Curr Opin Pharmacol 2:630–641
Liu DM, Cuevas J, Adams DJ (2000) VIP and PACAP potentiation of
nicotinic ACh-evoked currents in rat parasympathetic neurons is
mediated by G-protein activation. Eur J Physiol 12:2243–2251
Margiotta JF, Pardi D (1995) Pituitary adenylate cyclase-activating poly-
peptide type I receptors mediate cyclic AMP-dependent enhance-
ment of neuronal acetylcholine sensitivity.Mol Pharmacol 48:63–71
Masuo Y, Matsumoto Y, Tokito F, Tsuda M, Fujino M (1993) Effects of
vasoactive intestinal polypeptide (VIP) and pituitary adenylate cy-
clase activating polypeptide (PACAP) on the spontaneous release of
acetylcholine fron the rat hippocampus by brainmicrodialysis. Brain
Res 611:207–215
Parkman HP, Pagano AP, Ryan JP (1997) Dual effects of PACAP on
guinea pig gallbladder muscle via PACAP-preferring and VIP/
PACAP-preferring receptors. Am J Phys 272:G1433–G1438
Payet MD, Bilodeau L, Braeault L, Fournier A, Yon L, Vaudry H, Gallo-
Payet N (2003) PAC1 receptor activation by PACAP-38 mediates
Ca2+ release from a cAMP-dependent pool in human fetal adrenal
gland chromaffin cells. J Biol Chem 278:1663–1670
Pirger Z, Laszlo Z, Hiripi L, Hernádi L, Toth G, Lubics A, Reglodi D,
Kemenes G, Mark L (2010) Pituitary adenylate cyclase activating
polypeptide (PACAP) and its receptors are present and
biochemically active in the central nervous system of the pond snail
Lymnaea stagnalis. J Mol Neurosci 42:464–471
Pugh PC, Jayakar SS, Margiotta JF (2010) PACAP/PAC1R signaling
modulates acetylcholine release at neuronal nicotinic synapses.
Mol Cell Neurosci 43:244–257
Rattan S, Chakder S (1997) Excitatory and inhibitory actions of pituitary
adenyalte cyclase-activating peptide (PACAP) in the internal anal
sphincter smooth muscle:sites of actions. J Pharmacol Exp Ther
283:722–728
Roberto M, Brunelli M (2000) PACAP-38 enhances excitatory synaptic
transmission in the rat hippocampal CA1 region. LearnMem 7:303–
311
Schworer H, Katsoulis S, Creutzfeldt W, Schmidt WE (1992) Pituitary
adenylate cyclase activating peptide, a novel VIP-like gut-brain pep-
tide, relaxes the guinea pig taenia caeci via apamin-sensitive potas-
sium channels. Naunyn Schmiedeberg’s Arch Pharmacol 346:511–
514
Sherwood NM, Krueckl SL, McRory JE (2000) The origin and function
of the pituitary adenylate cyclase-activating polypeptide (PACAP)/
glucagon superfamily. Endocr Rev 21:619–670
Takeuchi T, Yamazaki Y, Negoro T, Fujijami K, Mukai K, Fujita A,
Takewaki T, Hata F (2004) Changes in mechanism of PACAP-
induced relaxation in longitudinal muscle of the distal colon of
Wistar rats with age. Regul Pept 118:1–9
Vamos Z, Ivic I, Cseplo P, Toth G, Tamas A, Reglodi D, Koller A (2014)
Pituitary adenylate cyclase-activating polypeptide (PACAP) induces
relaxations of peripheral and cerebral arteries, which are differential-
ly impaired by aging. J Mol Neurosci 54:535–542
Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O,
Fournier A, Chow BKC, Hashimoto H, Galas L, et al. (2009)
Pituitary adenylate cyclase-activating polypeptide and its receptors:
20 years after the discovery. Pharmacol Rev 61:283–357
Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y (2002) Effect of pituitary
adenylate cyclase-activating peptide on isolated rabbit iris sphincter
and dilator muscles. Invest Ophthalmol Vis Sci 43:780–783
Zhong Y, Pena LA (1995) A novel synaptic transmission mediated by a
PACAP-like neuropeptide in Drosophila. Neuron 14:527–536
Zizzo MG, Mulé F, Serio R (2004) Interplay between PACAP and NO in
mouse ileum. Neuropharmacology 46:449–455
500 J Mol Neurosci (2015) 57:492–500
